JFJohn A. Ferraro

John A. Ferraro

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


John A. Ferraro has a total of 15 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Electrocochleography: New Uses for an Old Test and Normative Values

    by John A. Ferraro, Paul R. Kileny, Signe S. Grasel

    Purpose This article combines the results of 3 studies that were presented at the HeAL 2018 Conference in Lake Como, Italy, in June 2018. Each study involved electrocochleography (ECochG), a neurodiagnostic evaluation that has been used clinically for over 80 years but whose applications continue to expand. The 1st study describes recent research wherein ECochG was recorded from asymptomatic subjects who were siblings or offspring of patients with a confirmed diagnosis of Ménière's disease (MD). Our results provide evidence that ECochG may be helpful in not only diagnosing MD but also predicting it as well. Second, case studies are described where ECochG was important in both diagnosing superior semicircular canal dehiscence and monitoring the repair of this condition during surgery. Finally, although ECochG has been practiced clinically for over 8 decades, the protocols for recording, measuring, and interpreting the electrocochleogram continue to lack standardization among clinicians and scientists. We thus present normative data for some of these features based on noninvasive recordings made from the tympanic membrane from 100 normal hearing subjects. Conclusions Although the primary use of ECochG continues to be in the diagnosis of MD, we report on 2 additional clinical applications for this important test of inner ear/auditory nerve function. First, a preliminary study on a small sample of subjects indicates that ECochG may also be useful in predicting MD prior to the onset of symptoms in individuals who may be genetically predisposed to developing it. Second, through a series of case studies, we demonstrate how ECochG is used to help diagnose superior semicircular canal dehiscence and monitor the status of the inner ear during the surgical repair of this condition. Finally, normative values for clinically important components of the electrocochleogram based on tympanic membrane recordings have been established from a large sample of subjects.


  • Open Access

    Normative data for TM electrocochleography measures

    by Signe Schuster Grasel, Roberto Miquelino de Oliveira Beck, Ricardo Silva Chiabai Loureiro, Amanda Costa Rossi, Edigar Rezende de Almeida, John Ferraro

    Establish normative data for tympanic electrocochleography (TM ECochG) parameters in normal hearing adults without Ménière's disease's (MD) symptoms. Describe TM ECochG variables that help to distinguish normal from MD ears. We enrolled 100 subjects (N = 200 ears), 59 females, aged between 19 and 71 years from 09/2010 to 04/2014. Inclusion criteria: normal otomicroscopy, hearing thresholds ≤25 dB nHL from 250 to 4000 Hz, normal tympanogram, no symptoms of MD according to the AAO-HNS 1995 criteria and Gibson's score <7. We excluded subjects with dizziness, aural fullness or other symptoms of endolymphatic hydrops. The following parameters were analyzed: SP/AP amplitude ratio, SP/AP area ratio and the difference between AP latency with rarefaction and condensation stimuli. There was no significant difference between right and left ears (Intraclass correlation coefficient < 0.6). SP/AP amplitude ratio varied between 0.084 and 0.356 and SP/AP area ratio between 0.837 and 1.671 (percentiles 5 and 95). The AP latency difference to rarefaction and condensation clicks was between 0.0 and 0.333 ms. Normative data for TM ECochG parameters were established in 100 normal hearing subjects without MD. These data can be used to distinguish normal from pathological findings and in follow-up of MD patients.


  • Electrocochleography: A Review of Recording Approaches, Clinical Applications, and New Findings in Adults and Children

    by John A. Ferraro

    Research related to expanding and improving the clinical use of electrocochleography (ECochG) has been ongoing for 25 yr at the University of Kansas Medical Center. This article presents highlights of findings from our laboratory during this period that have contributed to current ECochG recording approaches and clinical applications. A review of new data related to improving the sensitivity of ECochG in the diagnosis of Ménière's disease, the use of an ear canal recording approach for improving auditory brain stem response testing in newborns, and technical aspects related to recording the cochlear microphonic in newborns also will be presented.


  • Emerging Models of AuD-to-PhD Education

    by John Ferraro, Loretta Nunez

    After more than 50 years of evolution, the audiology profession has made the transition to doctoral-level entry for clinical practice. Three enrollment models attempt to bridge AuD-to-PhD education—sequential, simultaneous, and dual-track programs.

  • Electrocochleography in the Evaluation of Patients with Ménière's Disease/Endolymphatic Hydrops

    by John A. Ferraro, John D. Durrant

    Electrocochleography (ECochG) has evolved as an important tool in the diagnosis/assessment/monitoring of Ménière's disease/endolymphatic hydrops (MD/ELH). This manuscript provides an update on the use of ECochG for these purposes. The material presented includes descriptions of the components of the electrocochleogram; ECochG recording approaches and parameters; how to prepare for an exam, including subject/patient considerations; construction and placement of a tympanic membrane recording electrode; and interpretation the electrocochleogram. Various approaches aimed at improving ECochG's sensitivity and specificity to MD/ELH also are described. These approaches go beyond simple measurement of the now-conventional summating potential (SP)/action potential (AP) magnitude ratio to include the SP magnitude to tonebursts, the SP/AP area ratio, and the AP latency difference to clicks of opposing polarity. Spanish La electrococleografía (ECochG) ha evolucionado como una importante herramienta en el diagnóstico, evaluación y monitoreo de la enfermedad de Ménière-hydrops endolinfático (MD/HEL). Este manuscrito aporta una actualización en el uso de la ECochG para estos propósitos. El material presentado incluye descripción de los componentes del electrococleograma; parámetros y enfoques de registro del ECochG; cómo prepararse para un examen, incluyendo consideraciones para el sujeto/paciente; construcción y colocación de un electrodo de registro en la membrana timpánica, e interpretación del electrococleograma. Se describen también varios enfoques orientados a mejorar la sensibilidad y la especificidad de la ECochG en la MD/HEL. Estos enfoques van más allá de la simple medición de la convencional tasa de magnitud del potencia de suma (SP)/potencial de acción (AP), e incluyen la magnitud del SP para bursts tonales, la tasa de área de SP/AP y la diferencia de latencia del AP a clics de polaridad opuesta.


  • SP/AP Area Ratio in the Diagnosis of Ménière's Disease

    by John A. Ferraro, Richard P. Tibbils

    Conventional analysis of the click-evoked electrocochleogram includes measurement of the amplitudes of the cochlear summating potential (SP) and auditory nerve action potential (AP) to derive the SP/AP amplitude ratio. It is now well documented that an amplitude ratio where SP is elevated relative to AP may be a positive finding for endolymphatic hydrops in patients suspected of having Meniere's disease (MD). However, the incidence of an elevated SP/AP amplitude ratio in the general MD population is only ≈60%. This relatively low value necessitates efforts to improve the diagnostic sensitivity of electrocochleography (ECochG) for MD. A review of early and more recent literature in this area indicates that consideration of both the amplitude and duration of ECochG components may help to achieve this goal. The present study combined these features to measure the "area" of the SPAP complex in normal and MD populations. A software routine was used to measure the amplitude x duration area of the SP-AP complex in (a) normally hearing adults with normal SP/AP amplitude ratios (Group 1), (b) confirmed MD patients with elevated SP/AP amplitude ratios (Group 2), and (c) probable MD patients with normal SP/AP amplitude ratios (Group 3). Ninety percent of the confirmed MD patients in Group 2 displayed elevated SP/AP area ratios relative to the normative value established from Group 1. In addition, almost half of the probable MD patients from Group 3 displayed elevated area ratios. These findings indicate that measurement of the SP/AP area ratio holds promise for improving the sensitivity of ECochG in the diagnosis of MD.


  • Cochlear Potentials in Clinical Audiology

    by John A. Ferraro, Geetha Krishnan

    The recording of cochlear and auditory nerve potentials in humans via Electrocochleography (ECochG) has emerged as a valuable tool for a variety of clinical applications. This review consolidates current research on the use of cochlear potentials Ménière’s disease/ and ECochG in the clinical setting and identifies several areas in need of additional study. Methodological topics discussed include a review of ECochG recording approaches (i.e. trans-tympanic versus extratympanic) and issues related to choice of stimuli (clicks versus tonebursts). The review of current applications for cochlear potentials focuses primarily on the use of ECochG in the identification and treatment of Ménière’s disease/endolymphatic hydrops (MD/ELH). Other uses for ECochG also are presented (e.g. intraoperative monitoring, enhancement of ABR wave I, estimation of hearing sensitivity). Several suggestions are offered to maximize the predictive value of ECochG in the diagnosis of MD/ELH.


  • Recommended Guidelines for Reporting AEP Specifications

    by John A. Ferraro, John D. Durrant, Yvonne S. Sininger, Kathleen Campbell